Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal
- PMID: 4744596
Item in Clipboard
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal
Natl Cancer Inst Monogr.
1973 May.
No abstract available
Similar articles
-
Single-agent therapy for Hodgkin's disease.Arch Intern Med. 1973 Mar;131(3):377-87. Arch Intern Med. 1973. PMID: 4631683 Review. No abstract available.
-
Current chemotherapeutic combinations.Ser Haematol. 1973;6(2):182-95. Ser Haematol. 1973. PMID: 4593779 Review. No abstract available.
-
The treatment of Hodgkin's disease.Trans Med Soc Lond. 1972;88:61-71. Trans Med Soc Lond. 1972. PMID: 4665820 No abstract available.
-
Combination chemotherapy and survival in advanced Hodgkin's disease.Arch Intern Med. 1973 Mar;131(3):388-90. Arch Intern Med. 1973. PMID: 4569375 Clinical Trial. No abstract available.
-
Combination chemotherapy in advanced and recurrent Hodgkin's disease.Natl Cancer Inst Monogr. 1973 May;36:395-402. Natl Cancer Inst Monogr. 1973. PMID: 4744597 No abstract available.
Cited by
-
A comparison of the effects of prednisolone and methylprednisolone on human lymphoblastoid cells.Biochem J. 1977 Nov 15;168(2):323-4. doi: 10.1042/bj1680323. Biochem J. 1977. PMID: 597275 Free PMC article.
-
Effect of methylprednisolone on the nucleoside metabolism of a human lymphoblastoid cell line.Br J Cancer. 1977 Aug;36(2):187-91. doi: 10.1038/bjc.1977.176. Br J Cancer. 1977. PMID: 269741 Free PMC article.